kabutan

VITAL KSK HOLDINGS,INC.(3151) Summary

3151
TSE Prime
VITAL KSK HOLDINGS,INC.
1,283
JPY
-8
(-0.62%)
Dec 5, 3:30 pm JST
8.29
USD
Dec 5, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.3
PBR
0.57
Yield
5.30%
Margin Trading Ratio
7.81
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,286 JPY 8.28 USD
Previous Close Dec 4
1,291 JPY 8.30 USD
High Dec 5, 1:07 pm
1,291 JPY 8.33 USD
Low Dec 5, 9:03 am
1,283 JPY 8.26 USD
Volume
83,800
Trading Value
0.11B JPY 0.70M USD
VWAP
1285.6 JPY 8.31 USD
Minimum Trading Value
128,300 JPY 829 USD
Market Cap
0.07T JPY 0.43B USD
Number of Trades
252
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
301
1-Year High May 14, 2025
1,031
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 600 161,000 268.33
Nov 21, 2025 800 173,800 217.25
Nov 14, 2025 4,400 197,600 44.91
Nov 7, 2025 5,400 193,700 35.87
Oct 31, 2025 6,500 184,200 28.34
Company Profile
VITAL KSK HOLDINGS, INC. is the result of a merger between pharmaceutical wholesalers Vital Net and KSK, operating in the Tohoku and Kansai regions. The company also engages in nursing care consulting and veterinary pharmaceutical distribution.
Sector
Wholesale Trade
VITAL KSK HOLDINGS, INC. operates in four main business segments: pharmaceutical wholesale, pharmacy operations, veterinary pharmaceutical wholesale, and other businesses. In the pharmaceutical wholesale segment, Vital Net and KSK function as key subsidiaries. The pharmacy segment involves multiple subsidiaries managing dispensing pharmacies. The company's other business activities include retail sales of pharmaceuticals, wholesale of agricultural chemicals, transportation services, nursing care services, medical institution consulting, insurance agency services, real estate brokerage, and parking lot operations. The group, comprising the company itself along with its subsidiaries and affiliates, provides comprehensive healthcare services across a wide range of business areas.